Athira Pharma OverviewAthira Pharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ATHA.
Quarterly EBIT
-$17.21M
↓ 80.52% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$110.60M
↓ 33.65% YoY
Trailing 12 months ending Mar 31, 2026
Athira Pharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for ATHA.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026